VIJAYA2024-10-012024-12-31 VIJAYA2024-10-012024-12-31 VIJAYA2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member VIJAYA2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member VIJAYA2024-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 543350 VIJAYA NOTLISTED Vijaya Diagnostic Centre Limited Equity 2024-04-01 2025-03-31 2025-02-12 2025-02-06 INR Lakhs Third quarter 12:30:00 13:30:00 2025-02-12 2025-02-12 Not applicable Single segment Diagnostic Services 2024-10-01 2024-12-31 Unaudited Consolidated 1689826000.00 46970000.00 1736796000.00 208525000.00 0.00 0.00 285548000.00 68197000.00 183046000.00 524434000.00 1269750000.00 467046000.00 0.00 467046000.00 93441000.00 20616000.00 114057000.00 0.00 352989000.00 0.00 0.00 0.00 0.00 352989000.00 -278000.00 352711000.00 351563000.00 1426000.00 351285000.00 1426000.00 102629000.00 1 3.42 3.42 0.00 0.00 3.42 3.42 0.00 0.00 0.00 1. The above consolidated financial results of Vijaya Diagnostic Centre Limited ( the Company ) and its subsidiaries (the Company and its subsidiaries together referred to as the Group ) have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards ( Ind AS ) prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with the relevant rules thereunder, other accounting principles generally accepted in India and is in compliance with the presentation and disclosure requirements of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, (as amended). 2. The above consolidated financial results were reviewed by the audit committee and approved by the Board of Directors in their respective meetings held on 12 February 2025. The statutory auditors have carried out limited review of the above results for the quarter and year-to-date ended 31 December 2024. An unmodified report has been issued by them thereon. 3. The Group has one reportable segment (viz. Diagnostic Services) as per the requirements of Ind AS 108 Operating Segments . 4. During the previous year, the Company incurred an amount of Rs. 205 lakhs for the evaluation of various acquisitions towards financial, legal and tax due diligence and for market study on the diagnostic business in target geographies. These expenses had been categorised as exceptional items as these are not incurred in the ordinary course of business of operations of the Company. 5. During the quarter and year-to-date ended 31 December 2024, the Company has issued 7,652 and 2,83,769 equity shares of face value of Re. 1/- each respectively on exercise of employee stock options. 6. The Board of Directors of the Company in their meeting held on 26 June 2024, have considered and approved the proposed Scheme of Amalgamation ('Scheme ) wherein Medinova Diagnostic Services Limited (Subsidiary Company) would merge into the Company with effect from 01 April 2024 (‘the Appointed Date”) under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013, and other rules and regulations framed thereunder ( Scheme ). The Company has received letter with “no adverse observations” from the BSE Limited, NSE Limited and SEBI on December 05, 2024, and further the scheme is subject to the approval of Shareholders and Creditors of the respective companies and National Company Law Tribunal, and such other approvals, permissions, and sanctions of regulatory and other authorities as may be necessary. 7. The results of the Group are available for investors at www.vijayadiagnostic.com, www.nseindia.com and www.bseindia.com. Single segment 2024-04-01 2024-12-31 Unaudited Consolidated 5081476000.00 127709000.00 5209185000.00 625983000.00 0.00 0.00 837500000.00 195532000.00 517760000.00 1574475000.00 3751250000.00 1457935000.00 0.00 1457935000.00 317790000.00 50857000.00 368647000.00 0.00 1089288000.00 0.00 0.00 0.00 0.00 1089288000.00 -962000.00 1088326000.00 1084379000.00 4909000.00 1083417000.00 4909000.00 102629000.00 1 10.57 10.55 0.00 0.00 10.57 10.55 0.00 0.00 0.00 Other expenses 524434000.00 Other expenses 1574475000.00 -372000.00 -1286000.00 -94000.00 -324000.00 0.00 0.00